Oct 20, 2025 · Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular and kidney risks by regulating appetite and blood sugar.

Semaglutide is a glucagon-like peptide-1 receptor agonist. [13][14][15] The drug decreases blood sugar levels. The decrease is theorized to be caused by the mimicking of glucagon-like …

Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular …

Jul 17, 2025 · Physiological implications: Semaglutide is a synthetic analog of human GLP-1, designed to resist degradation by DPP-4 enzyme, enhancing its half-life and efficacy. GLP-1 …

Dec 1, 2025 · Semaglutide is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, which is a type of incretin mimetic. These drugs work by mimicking the natural incretin …

Semaglutide is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.

Feb 26, 2025 · Semaglutide is the active ingredient in certain brand-name medications prescribed for obesity, type 2 diabetes, and more. Semaglutide belongs to the glucagon-like peptide-1 …

Jul 30, 2025 · It’s a GLP-1 receptor agonist a class of drugs that mimic the effects of a natural hormone (GLP-1) which regulates blood sugar and appetite. How it works: Slows down …

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which belongs to the incretin mimetic class of drugs. Semaglutide is indicated for: Type 2 diabetes mellitus (T2DM): To …

While Ozempic is the blockbuster medication everyone’s talking about weight loss, the active ingredient – semaglutide – is part of a class of medications that work in a similar way.